Browsing Tag
cenobamate
3 posts
Bajaj Healthcare (NSE: BAJAJHCARE) rallies 16% on Cenobamate approval milestone
BAJAJHCARE surged on India’s first Cenobamate recommendation. Final approval and launch economics must now justify the ₹1,183 crore valuation.
Bajaj Healthcare (NSE: BAJAJHCARE) Q3 FY26 earnings: API exports double, PAT up 34%
Bajaj Healthcare’s API exports doubled in Q3 FY26, driving 31% revenue growth. Find out what its CNS pipeline and CDMO ramp mean for future expansion.
SK Biopharmaceuticals launches phase 3 trial of seizures drug cenobamate in Asia
SK Biopharmaceuticals, a South Korean pharma company, has revealed plans to initiate a phase 3 clinical trial for…